Mediana Acquires Technology and Patents for Automated Chest Compression Device View original image

[Asia Economy Reporter Kim Young-won] Mediana has secured CPR (automated CPR device) technology that automatically performs chest compressions on cardiac arrest patients, classified as a medical device class 3.


Mediana announced on the 7th that it has signed a contract to acquire all patents and know-how related to automatic chest compression devices.


This device, also known as an electric cardiopulmonary resuscitation device, is a medical device that automatically performs chest compressions at a consistent rhythm and pressure during the initial emergency treatment stage by bystanders or medical personnel who discover a patient experiencing cardiac arrest in disaster and emergency situations.


Mediana explained that the acquired technology focuses on automatic chest compression devices, making them smaller, lighter, and capable of long-term use, thereby enhancing usability in emergency situations.


Furthermore, this contract was promoted to expand distribution with competitive pricing and quality to enable effective response through automatic chest compression devices during disasters, and it is scheduled to be launched in the market by mid-next year. The company expects synergistic effects when sold together with its AED (automated external defibrillator).


Since chest compressions must be continuously maintained without interruption in any environment, the device can be used during transport or inside negative pressure transport units. There has been a need to develop lightweight automatic CPR devices that rescuers can easily carry and move at disaster sites. Mediana expects the market to expand as the automatic CPR device can be installed in hospital emergency rooms, intensive care units, and wards once launched.



Gil Moon-jong, Chairman of Mediana, said, "By developing and launching an automatic CPR device applying the acquired technology, we will become a leader in the emergency medical market alongside our automated external defibrillators, which are the first in Korea to receive European MDR CE and UK UKCA certifications, as well as hospital defibrillators."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing